Genetic Technologies Limited (GNTLF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 7.66 Million AUD | -11.76% |
| 2023 | 8.68 Million AUD | 27.83% |
| 2022 | 6.79 Million AUD | 5536.33% |
| 2021 | 120.55 Thousand AUD | 1122.16% |
| 2020 | 9864.00 AUD | -61.23% |
| 2019 | 25.44 Thousand AUD | -86.56% |
| 2018 | 189.25 Thousand AUD | -63.5% |
| 2017 | 518.5 Thousand AUD | -37.12% |
| 2016 | 824.58 Thousand AUD | -59.01% |
| 2015 | 2.01 Million AUD | -55.92% |
| 2014 | 4.56 Million AUD | 35.15% |
| 2013 | 3.37 Million AUD | -70.2% |
| 2012 | 11.33 Million AUD | -38.0% |
| 2011 | 18.27 Million AUD | 87.31% |
| 2010 | 9.75 Million AUD | 46.3% |
| 2009 | 6.66 Million AUD | -57.62% |
| 2008 | 15.73 Million AUD | 14.37% |
| 2007 | 13.75 Million AUD | 39.0% |
| 2006 | 9.89 Million AUD | 4.53% |
| 2005 | 9.46 Million AUD | 150.29% |
| 2004 | 3.78 Million AUD | -59.16% |
| 2003 | 9.26 Million AUD | -29.32% |
| 2002 | 13.1 Million AUD | 132.68% |
| 2001 | 5.63 Million AUD | 40.17% |
| 2000 | 4.01 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 7.66 Million AUD | -11.76% |
| 2024 Q2 | 3.95 Million AUD | 62.47% |
| 2024 Q1 | 2.43 Million AUD | -46.24% |
| 2024 Q4 | 3.7 Million AUD | 0.0% |
| 2023 Q1 | 2.48 Million AUD | -47.53% |
| 2023 Q3 | 2.68 Million AUD | -35.36% |
| 2023 Q2 | 4.15 Million AUD | 66.9% |
| 2023 FY | 8.68 Million AUD | 27.83% |
| 2023 Q4 | 4.53 Million AUD | 68.79% |
| 2022 Q3 | 2.88 Million AUD | 40.5% |
| 2022 Q1 | 1.72 Million AUD | 1559.16% |
| 2022 FY | 6.79 Million AUD | 5536.33% |
| 2022 Q2 | 2.05 Million AUD | 18.73% |
| 2022 Q4 | 4.74 Million AUD | 64.62% |
| 2021 Q4 | 104.11 Thousand AUD | -84.2% |
| 2021 Q1 | 8218.00 AUD | -11.42% |
| 2021 Q2 | 16.43 Thousand AUD | 100.0% |
| 2021 Q3 | 659.14 Thousand AUD | 3910.4% |
| 2021 FY | 120.55 Thousand AUD | 1122.16% |
| 2020 Q1 | 293.00 AUD | -95.84% |
| 2020 Q2 | 586.00 AUD | 100.0% |
| 2020 Q3 | 4639.00 AUD | 691.64% |
| 2020 Q4 | 9278.00 AUD | 100.0% |
| 2020 FY | 9864.00 AUD | -61.23% |
| 2019 Q4 | 7042.00 AUD | 100.0% |
| 2019 Q1 | 9201.00 AUD | -79.88% |
| 2019 Q2 | 9201.00 AUD | 0.0% |
| 2019 FY | 25.44 Thousand AUD | -86.56% |
| 2019 Q3 | 3521.00 AUD | -61.73% |
| 2018 Q3 | 45.73 Thousand AUD | -6.47% |
| 2018 Q1 | 48.89 Thousand AUD | -34.53% |
| 2018 FY | 189.25 Thousand AUD | -63.5% |
| 2018 Q2 | 48.89 Thousand AUD | 0.0% |
| 2018 Q4 | 45.73 Thousand AUD | 0.0% |
| 2017 Q2 | 184.56 Thousand AUD | 0.0% |
| 2017 FY | 518.5 Thousand AUD | -37.12% |
| 2017 Q4 | 74.68 Thousand AUD | 0.0% |
| 2017 Q3 | 74.68 Thousand AUD | -59.54% |
| 2017 Q1 | 184.56 Thousand AUD | -14.46% |
| 2016 Q3 | 215.76 Thousand AUD | 9.79% |
| 2016 Q4 | 215.76 Thousand AUD | 0.0% |
| 2016 Q2 | 196.52 Thousand AUD | 0.0% |
| 2016 Q1 | 196.52 Thousand AUD | -48.27% |
| 2016 FY | 824.58 Thousand AUD | -59.01% |
| 2015 FY | 2.01 Million AUD | -55.92% |
| 2015 Q4 | 379.87 Thousand AUD | 0.0% |
| 2015 Q3 | 379.87 Thousand AUD | -39.33% |
| 2015 Q2 | 626.08 Thousand AUD | 0.0% |
| 2015 Q1 | 626.08 Thousand AUD | -50.84% |
| 2014 Q4 | 1.27 Million AUD | 0.0% |
| 2014 FY | 4.56 Million AUD | 35.15% |
| 2014 Q1 | 1 Million AUD | 24.58% |
| 2014 Q2 | 1 Million AUD | -0.0% |
| 2014 Q3 | 1.27 Million AUD | 26.26% |
| 2013 FY | 3.37 Million AUD | -70.2% |
| 2013 Q4 | 809.65 Thousand AUD | 0.0% |
| 2013 Q3 | 809.65 Thousand AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | 11.33 Million AUD | -38.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | 18.27 Million AUD | 87.31% |
| 2011 Q2 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | 9.75 Million AUD | 46.3% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | 6.66 Million AUD | -57.62% |
| 2008 FY | 15.73 Million AUD | 14.37% |
| 2008 Q2 | 4.54 Million AUD | 2.72% |
| 2008 Q1 | 4.42 Million AUD | -30.1% |
| 2008 Q4 | 3.33 Million AUD | -49.76% |
| 2008 Q3 | 6.63 Million AUD | 46.04% |
| 2007 Q1 | 2.7 Million AUD | 23.61% |
| 2007 FY | 13.75 Million AUD | 39.0% |
| 2007 Q2 | 2.02 Million AUD | -25.26% |
| 2007 Q3 | 4.24 Million AUD | 109.46% |
| 2007 Q4 | 6.32 Million AUD | 49.14% |
| 2006 FY | 9.89 Million AUD | 4.53% |
| 2006 Q1 | 3.37 Million AUD | 426.69% |
| 2006 Q2 | 3.37 Million AUD | 0.01% |
| 2006 Q3 | 2.56 Million AUD | -23.91% |
| 2006 Q4 | 2.19 Million AUD | -14.72% |
| 2005 Q2 | 3.51 Million AUD | -6.74% |
| 2005 FY | 9.46 Million AUD | 150.29% |
| 2005 Q1 | 3.76 Million AUD | 0.0% |
| 2005 Q3 | 3.55 Million AUD | 1.17% |
| 2005 Q4 | -1.03 Million AUD | -129.1% |
| 2004 FY | 3.78 Million AUD | -59.16% |
| 2003 FY | 9.26 Million AUD | -29.32% |
| 2002 FY | 13.1 Million AUD | 132.68% |
| 2001 FY | 5.63 Million AUD | 40.17% |
| 2000 FY | 4.01 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -739.516% |
| Arrayit Corporation | 4.37 Million USD | -75.103% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 70.358% |
| Bioqual, Inc. | 58.59 Million USD | 86.918% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 49.89% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.896% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -20.398% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -628.876% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 80.94% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -1612.805% |
| InVitro International | 792.62 Thousand USD | -867.009% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 31.14% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -6.098% |
| NovelStem International Corp. | 12 Thousand USD | -63773.2% |
| Optigenex Inc. | 465.97 Thousand USD | -1544.909% |
| PharmChem, Inc. | 6.01 Million USD | -27.483% |
| Proteome Sciences plc | 6.4 Million USD | -19.75% |
| Response Genetics, Inc | 18.04 Million USD | 57.512% |
| Rennova Health, Inc. | 13.03 Million USD | 41.204% |
| RushNet, Inc. | 1.78 Million USD | -328.708% |
| ScreenPro Security Inc. | 1.91 Million USD | -300.437% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -101.967% |
| Todos Medical Ltd. | 7.69 Million USD | 0.393% |